Ticker Details
Edwards Lifesciences Corp Edwards Lifesciences Corp is a part of the healthcare sector. The company specializes in the treatment of structural heart disease. It manufactures heart valves and repair products used to replace or repair a patient's diseased or defective heart valve.
IPO Date:	April 3, 2000
Sector:	Healthcare
Industry:	Health Care Equipment and Supplies
Market Cap:	$46.3B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.97 | 1.07%
Avg Daily Range (30 D):	$0.93 | 1.15%
Avg Daily Range (90 D):	$0.91 | 1.11%

Institutional Daily Volume
Avg Daily Volume:	3.73M
Avg Daily Volume (30 D):	3.77M
Avg Daily Volume (90 D):	3.3M

Trade Size
Avg Trade Size (Sh.):	235
Avg Trade Size (Sh.) (30 D):	66
Avg Trade Size (Sh.) (90 D):	62

Institutional Trades
Total Institutional Trades:	28,322
Avg Institutional Trade:	$6.13M
Avg Institutional Trade (30 D):	$7.03M
Avg Institutional Trade (90 D):	$8.09M
Avg Institutional Trade Volume:	.15M
Avg Institutional Trades (Per Day):	5

Market Closing Trades
Avg Closing Trade:	$21.92M
Avg Closing Trade (30 D):	$55.51M
Avg Closing Trade (90 D):	$54.73M
Avg Closing Volume:	404.39K

News

Feb 20, 2026 @ 5:02 AM ORBIMED Advisors Trims $125 Million Terns Stake Af... Source: Eric Trie

Feb 17, 2026 @ 9:00 AM Pulmonary Artery Catheter Market Size to Reach USD... Source: Sns Insider

Jan 15, 2026 @ 1:42 PM Boston Scientific Acquires Penumbra In $14.5 Billi... Source: Akanksha Bakshi

Jan 12, 2026 @ 2:31 PM Court Ruling Ends Edwards Lifesciences $1.2 Billio... Source: Vandana Singh

Jan 12, 2026 @ 12:52 PM Global Catheters Market Size to Hit USD 55.58 Bill... Source: Sns Insider

Financials
	TTM	Q3 2025	Q2 2025
Basic EPS		$.5	$.57
Diluted EPS		$.5	$.56
Revenue		$1.55B	$1.53B
Gross Profit		$1.21B	$1.19B
Net Income / Loss		$290.3M	$331.5M
Operating Income / Loss		$307.1M	$411.2M
Cost of Revenue		$345.2M	$344.4M
Net Cash Flow		$-595.2M	$141.2M
PE Ratio

Splits
Jun 01, 2020	3:1
Dec 14, 2015	2:1
May 28, 2010	2:1